Healthcare Sales & Marketing Network News: Delafloxacin

Searching News Database: Delafloxacin

HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 29 Nov 2012
Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Apr 2012
Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Mar 2010
Rib-X Appoints Mark Leuchtenberger as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Sep 2008
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors
Biopharmaceuticals Personnel

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.